Illumina Archives -

News/ News/ News/ Oncology/ Sales and Marketing

Commission can rule on Illumina, Grail merger, says EU court

Phil Taylor antitrust, diagnostics, European Commission, Galleri, Grail, Illumina, litigation, M&A, Oncology 0 Comment

Illumina’s attempt to prevent the European Commission from carrying out an antitrust review of its $8 billion takeover

Commission can rule on Illumina, Grail merger, says EU court

https://pharmaphorum.com/news/commission-can-rule-on-illumina-grail-merger-says-eu-court/

News/ News/ Patients

Illumina debuts its multi-gene test for cancer in Europe

Phil Taylor diagnosis, genome, Illumina, Oncology, rare disease, TruSight Oncology 0 Comment

Gene sequencing specialist Illumina has started rolling out a new test that looks for a battery of tumour-associated

Illumina debuts its multi-gene test for cancer in Europe

https://pharmaphorum.com/news/illumina-debuts-multi-gene-test-for-cancer-in-europe/

News/ News/ Patients/ Top stories

NHS England starts largest ever trial of Galleri cancer blood test

Phil Taylor cancer screening, diagnostic, Galleri, Grail, Illumina, liquid biopsy, NHS, NHS England, Oncology 0 Comment

A blood test called Galleri that could detect dozens of different forms of cancer before symptoms appear will

NHS England starts largest ever trial of Galleri cancer blood test

https://pharmaphorum.com/news/nhs-england-starts-largest-ever-trial-of-galleri-cancer-blood-test/

News/ News/ Oncology

Illumina wants to bring liquid biopsy spinout Grail back in-house; report

Phil Taylor diagnosis, Grail, Illumina, liquid biopsy, M&A, Oncology 0 Comment

Cancer diagnosis firm Grail could be re-joining Illumina, the company it was spun out of in 2016, despite

Illumina wants to bring liquid biopsy spinout Grail back in-house; report

https://pharmaphorum.com/news/illumina-wants-to-bring-liquid-biopsy-spinout-grail-back-in-house-report/

Market Access/ News/ News/ News/ Sales and Marketing

Roche and Illumina forge genomics alliance for cancer testing

Phil Taylor cancer diagnosis, Gene Sequencing, Illumina, Oncology, Roche 0 Comment

Roche missed out on acquiring next-generation sequencing (NGS) specialist Illumina via a hostile takeover a few years back,

Roche and Illumina forge genomics alliance for cancer testing

https://pharmaphorum.com/news/roche-and-illumina-forge-genomics-alliance-for-cancer-testing/

News

DNA sequencers Illumina and PacBio call off $1.2bn merger

Richard Staines Illumina, M&A, Pacific Biosciences, regulation 0 Comment

California-based DNA sequencing firms Illumina and Pacific Biosciences have called off their proposed $1.2 billion merger, after deciding

DNA sequencers Illumina and PacBio call off $1.2bn merger

https://pharmaphorum.com/news/dna-sequencers-illumina-and-pacific-call-off-1-2-bn-merger/

News/ News/ R&D

Illumina picks UK site for biotech startup engine

Richard Staines Illumina, R&D 0 Comment

Genomics firm Illumina is to foster biotech innovation in the UK by establishing a branch of its “Illumina

Illumina picks UK site for biotech startup engine

https://pharmaphorum.com/news/illumina-picks-uk-site-for-biotech-startup-engine/

News/ UK & Europe

Oxford Nanopore’s tech reaches genome sequencing landmark

Richard Staines cancer, cystic fibrosis, digital health, genetics, Illumina, medical devices, nanopore, Oxford Nanopore 0 Comment

Oxford Nanopore one of many firms cutting time and cost of sequencing

Oxford Nanopore’s tech reaches genome sequencing landmark

https://pharmaphorum.com/news/handheld-genome-sequencing-revolutionise-medicine/

Trending

Illumina

Login